chr3-8753808-C-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000916.4(OXTR):c.923-584G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 110,684 control chromosomes in the GnomAD database, including 957 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.10   (  957   hom.,  cov: 32) 
Consequence
 OXTR
NM_000916.4 intron
NM_000916.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.28  
Publications
10 publications found 
Genes affected
 OXTR  (HGNC:8529):  (oxytocin receptor) The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008] 
 CAV3  (HGNC:1529):  (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008] 
CAV3 Gene-Disease associations (from GenCC):
- caveolinopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant limb-girdle muscular dystrophy type 1CInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- long QT syndrome 9Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- rippling muscle disease 2Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- distal myopathy, Tateyama typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- inherited rippling muscle diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
- long QT syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.273  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.101  AC: 11137AN: 110618Hom.:  954  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
11137
AN: 
110618
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.101  AC: 11139AN: 110684Hom.:  957  Cov.: 32 AF XY:  0.101  AC XY: 5449AN XY: 54186 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
11139
AN: 
110684
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
5449
AN XY: 
54186
show subpopulations 
African (AFR) 
 AF: 
AC: 
8405
AN: 
30184
American (AMR) 
 AF: 
AC: 
679
AN: 
11030
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
94
AN: 
2424
East Asian (EAS) 
 AF: 
AC: 
734
AN: 
4718
South Asian (SAS) 
 AF: 
AC: 
281
AN: 
3344
European-Finnish (FIN) 
 AF: 
AC: 
74
AN: 
7394
Middle Eastern (MID) 
 AF: 
AC: 
7
AN: 
230
European-Non Finnish (NFE) 
 AF: 
AC: 
739
AN: 
49222
Other (OTH) 
 AF: 
AC: 
121
AN: 
1514
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 485 
 971 
 1456 
 1942 
 2427 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 120 
 240 
 360 
 480 
 600 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
264
AN: 
3462
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.